{"DataElement":{"publicId":"3121575","version":"2","preferredName":"Disease Detection Molecular Analysis Method Type","preferredDefinition":"Classification of a molecular analysis method used for an analysis.","longName":"DZ_DET_ANLY_METH_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2770350","version":"1","preferredName":"Disease Detection Molecular Analysis Method","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The activity of perceiving, discerning, discovering or identifying._Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA)._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"DIS_DET_MOL_ANA_MTH","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2770347","version":"1","preferredName":"Disease or Disorder Detection","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:No value exists.","longName":"C2991:C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53CEA9D9-0F1B-6B0F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-06","modifiedBy":"ONEDATA","dateModified":"2008-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2770348","version":"1","preferredName":"Molecular Analysis Method","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C19770:C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53CEA9D9-0F29-6B0F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-06","modifiedBy":"ONEDATA","dateModified":"2008-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53CEA9D9-0F3A-6B0F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3121569","version":"2","preferredName":"Molecular Analysis Type","preferredDefinition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._Type; a subdivision of a particular kind of thing.","longName":"MOL_ANLY_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDC4530-117F-941F-E040-BB89AD4362A6","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","deletedIndicator":"No"},{"value":"RT-PCR","valueDescription":"RT-PCR","ValueMeaning":{"publicId":"3121570","version":"1","preferredName":"RT-PCR","longName":"3121570","preferredDefinition":"RT-PCR is short for reverse transcriptase-polymerase chain reaction. It is a technique in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-E9B3-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDC4530-1189-941F-E040-BB89AD4362A6","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","deletedIndicator":"No"},{"value":"Southern","valueDescription":"Southern Blotting","ValueMeaning":{"publicId":"3121572","version":"1","preferredName":"Southern Blotting","longName":"3121572","preferredDefinition":"A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Southern Blotting","conceptCode":"C16356","definition":"A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-E9D9-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDC4530-1193-941F-E040-BB89AD4362A6","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","deletedIndicator":"No"},{"value":"FISH","valueDescription":"Fluorescence in situ Hybridization","ValueMeaning":{"publicId":"2581337","version":"1","preferredName":"Fluorescence in situ Hybridization","longName":"2581337","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0AC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-24","modifiedBy":"ONEDATA","dateModified":"2006-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDC4530-119D-941F-E040-BB89AD4362A6","beginDate":"2010-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","deletedIndicator":"No"},{"value":"IHC","valueDescription":"Immunohistochemistry Staining Method","ValueMeaning":{"publicId":"3031358","version":"1","preferredName":"Immunohistochemistry Staining Method","longName":"3031358","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F6B5AD-3994-79F8-E040-BB89AD430E7D","latestVersionIndicator":"Yes","beginDate":"2010-03-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-03-29","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDC4530-11A7-941F-E040-BB89AD4362A6","beginDate":"2010-09-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","deletedIndicator":"No"},{"value":"Nuclear Staining","valueDescription":"Nuclear Staining","ValueMeaning":{"publicId":"3628758","version":"1","preferredName":"Nuclear Staining","longName":"3628758","preferredDefinition":"Pertaining to the nucleus.: Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear","conceptCode":"C13361","definition":"Pertaining to the nucleus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Staining","conceptCode":"C50753","definition":"Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDC4530-11BB-941F-E040-BB89AD4362A6","latestVersionIndicator":"Yes","beginDate":"2012-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDC4530-11D4-941F-E040-BB89AD4362A6","beginDate":"2012-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"ONEDATA","dateModified":"2012-11-19","deletedIndicator":"No"},{"value":"NGS","valueDescription":"Next Generation Sequencing","ValueMeaning":{"publicId":"4448577","version":"1","preferredName":"Next Generation Sequencing","longName":"4448577","preferredDefinition":"Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Next Generation Sequencing","conceptCode":"C101293","definition":"Technologies that facilitate the rapid determination of the nucleotide sequence of large numbers of strands or segments of DNA or RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00760948-0C1D-42C2-E050-BB89AD434284","latestVersionIndicator":"Yes","beginDate":"2014-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"00760948-0C36-42C2-E050-BB89AD434284","beginDate":"2014-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-08-12","modifiedBy":"ONEDATA","dateModified":"2014-08-12","deletedIndicator":"No"},{"value":"Cytogenetics","valueDescription":"Cytogenetics","ValueMeaning":{"publicId":"5255755","version":"1","preferredName":"Cytogenetics","longName":"5255755","preferredDefinition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3292EEC4-49B7-D1A2-E050-BB89AD437087","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3292EEC4-49D0-D1A2-E050-BB89AD437087","beginDate":"2016-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-11","modifiedBy":"ONEDATA","dateModified":"2016-05-11","deletedIndicator":"No"},{"value":"Karyotype","valueDescription":"Karyotype","ValueMeaning":{"publicId":"5255756","version":"1","preferredName":"Karyotype","longName":"5255756","preferredDefinition":"The assessment of the chromosomal morphology and number in somatic cells of an individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Karyotype","conceptCode":"C25215","definition":"The chromosomal morphology and number in somatic cells of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3292EEC4-49DA-D1A2-E050-BB89AD437087","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3292EEC4-49F3-D1A2-E050-BB89AD437087","beginDate":"2016-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-11","modifiedBy":"ONEDATA","dateModified":"2016-05-11","deletedIndicator":"No"},{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"2770998","version":"1","preferredName":"Specify Other","longName":"2770998","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F45DBF-5E42-1D6F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-08-08","modifiedBy":"COOPERM","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D4DE3F-B7BA-4204-E053-F662850A8B4D","beginDate":"2018-02-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"Polymerase chain reaction (PCR)","valueDescription":"Polymerase Chain Reaction","ValueMeaning":{"publicId":"3234683","version":"1","preferredName":"Polymerase Chain Reaction","longName":"3234683","preferredDefinition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1572-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":"7-20-20 TMT updated concept with NCIt definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"874BA85D-C16B-6E6A-E053-F662850ACEC5","beginDate":"2019-04-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"Flow cytometry","valueDescription":"Flow Cytometry","ValueMeaning":{"publicId":"2974014","version":"1","preferredName":"Flow Cytometry","longName":"2974014","preferredDefinition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10AD-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"874BA85D-C175-6E6A-E053-F662850ACEC5","beginDate":"2019-04-24","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"Molecular","valueDescription":"Molecular","ValueMeaning":{"publicId":"2568065","version":"1","preferredName":"Molecular","longName":"2568065","preferredDefinition":"relating to or produced by or consisting of molecules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-14","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93DA59A4-1F52-1BB9-E053-F662850A536C","beginDate":"2019-10-01","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"Immunohistochemistry","valueDescription":"Immunohistochemistry Staining Method","ValueMeaning":{"publicId":"3031358","version":"1","preferredName":"Immunohistochemistry Staining Method","longName":"3031358","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F6B5AD-3994-79F8-E040-BB89AD430E7D","latestVersionIndicator":"Yes","beginDate":"2010-03-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-03-29","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C46D206F-5FCA-150D-E053-4EBD850A4426","beginDate":"2021-06-10","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-06-10","modifiedBy":"ONEDATA","dateModified":"2021-06-10","deletedIndicator":"No"},{"value":"Hercep Test","valueDescription":"Herceptest","ValueMeaning":{"publicId":"3718571","version":"1","preferredName":"Herceptest","longName":"3718571","preferredDefinition":"Test for identification of breast cancer patients with tumors that produce excessive amounts of the HER-2 protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HercepTest","conceptCode":"C25524","definition":"An FDA approved test for the evaluation of HER2 protein overexpression in breast tumors.  It provides semi-quantitative results of p185HER2 (HER2 gene) overexpression in Bouin or formalin-fixed, routinely processed, paraffin-embedded breast cancer tissues by light microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9D937BB-3A1B-8771-E040-BB89AD432B06","latestVersionIndicator":"Yes","beginDate":"2013-04-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7B75DFE-DE9C-2F37-E053-4EBD850A1BA3","beginDate":"2021-07-22","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-22","modifiedBy":"ONEDATA","dateModified":"2021-07-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3121568","version":"1","preferredName":"Molecular Analysis Type","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).:Type; a subdivision of a particular kind of thing.","longName":"C19770:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-E983-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"ONEDATA","dateModified":"2010-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDC4530-1169-941F-E040-BB89AD4362A6","latestVersionIndicator":"Yes","beginDate":"2012-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"TITARENI","dateModified":"2021-07-22","changeDescription":"PVs \"ICH\" and \"FISH\" added for The Cancer Genome Atlas (TCGA) by request of J. Gardner. 09/2010 sw.  v2.0 extends maximum length from 8 to 20 characters","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"disease_detection_molecular_analysis_method_type","type":"TCGA_XML_Name","context":"NCIP"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"Type of analysis","type":"Preferred Question Text","description":"Type of analysis","url":null,"context":"NCIP"},{"name":"Method","type":"Alternate Question Text","description":"Method","url":null,"context":"DCP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If yes, what type of testing was performed?","url":null,"context":"COG"},{"name":"COG CRF TEXT 2","type":"Alternate Question Text","description":"What type of testing was performed?","url":null,"context":"COG"},{"name":"NRG_CRF_TEXT1","type":"Alternate Question Text","description":"Positive ALK rearrangement method used","url":null,"context":"NRG"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Method of Detection","url":null,"context":"Theradex"},{"name":"If yes, what type of method is used to generate data?","type":"Alternate Question Text","description":"If yes, what type of method is used to generate data?","url":null,"context":"Theradex"},{"name":"Theradex - 2","type":"Alternate Question Text","description":"Test performed","url":null,"context":"Theradex"},{"name":"Princess Marg-1","type":"Alternate Question Text","description":"Molecular test","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CEDC4530-11E2-941F-E040-BB89AD4362A6","latestVersionIndicator":"Yes","beginDate":"2012-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-19","modifiedBy":"SOKKERL","dateModified":"2020-04-27","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 7/2010. v2.0 replaces v1.0 with a version VD that extends the maximum field length from 8 to 20 characters.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}